218P - Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Autor: Sonnenblick, A., Bailey, A., Uziely, B., Untch, M., Smith, I., Gianni, L., Baselga, J., Jackisch, C., Cameron, D., Bell, R., Zardavas, D., Al-Sakaff, N., Gelber, R., Dowsett, M., Leyland-jones, B., Piccart, M., de Azambuja, E.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect